Founder spotlight

Smaller groups deserve a benefit built around them.

Garrett Mineau, founder and CEO of RxDune

GARRETT MINEAU — FOUNDER & CEO

Before founding RxDune, Garrett worked inside the pharmacy benefits industry — helping small and large employer groups through their RFP processes and evaluating PBM contracts. Seeing that world up close left him with one conviction: smaller employer groups deserve a pharmacy benefit built specifically around them.

In his words

"Most pharmacy benefit platforms were built with the largest employers in mind — and they serve those clients well. But a 100-life company has different needs than a 10,000-life one. I wanted to build for that smaller group from day one: simple flat-fee pricing, 100% of rebates passed through, and real support when a member needs it.

What excites me most is that AI is what makes this possible — right now, for the first time. Prescription prices vary widely across pharmacies and channels, and no single option is the best every time. Capturing that means checking every channel on every single fill, and for a 100-life group, that math never worked before — the analysis cost more than the savings. AI flipped it. Now every prescription gets routed to the lowest-cost option automatically, whether the plan covers 100 people or 10,000. RxDune couldn't have been built five years ago.

And as pass-through contracts become the industry norm, small groups will still need what a contract alone can't deliver: real service, real-time visibility, and an engine that actually finds the lowest cost on every fill. That's the part we're building for.

The goal is simple: give employers with 50 to 1,000 employees the same quality of pricing and service the biggest companies have always had."

RxDune is an AI-native pharmacy benefit manager built for self-funded employers. Lower costs through smarter routing. Better care through smarter support.

Meet the team

Built by people who learned the industry from the inside.

BP

Blake Pickell

Founding Member

Blake spent five years at GoodRx through its IPO — ultimately VP of Business Solutions, building the products that brought drug-price transparency to millions of consumers and to funded health plans — and later led product at BuzzRx. A U.S. Air Force Academy graduate and former Air Force officer, he has led engineering, product, and operations teams from ten people to 250. At RxDune he leads our technology and AI build, bringing an operator's lens to how the platform is designed, shipped, and run.

LF

Lukas Fisher

Founding Member

Luke spent nearly seven years at GoodRx, ultimately as VP of Account Management, Sales & Strategy — owning the national PBM partnerships that drove the majority of the company's revenue, and learning the economics of the industry's biggest players from the inside. Before that he advised Fortune 500 and healthcare clients at EY and served as a U.S. Air Force acquisitions officer on multibillion-dollar space programs. At RxDune he leads the design of our operations and commercial development.

The mission

Give the smallest employers and their members the lowest true cost of every prescription — with the visibility and service only large groups have had — by routing every script to its best channel and keeping our incentives aligned with theirs, always.

Why now

Three shifts, pulling the same way.

01

Channels specialized.

Pharmacy channels now publish real-time prices, and each has optimized so hard for its niche that none wins outside it. The winning move stopped being "negotiate a better price" and became "route to the right channel every time."

02

AI made the operating layer real.

Adjudication, prior auth, formulary management, and audit-ready reporting are criteria-driven, document-heavy workflows — exactly what agentic systems just became production-ready to run.

03

Regulation is pulling the same way.

Washington is forcing PBM compensation away from drug prices and rebates toward disclosed fees and pass-through. Incumbents are scrambling to comply. We were built this way.

Trust, in plain terms

01

100% pass-through and $0 spread, written into the contract

02

Unrestricted audit rights — the plan picks the auditor

03

Fee disclosed in every proposal and fixed for the term

04

Human-in-the-loop AI: licensed professionals make every clinical decision

05

Honest about where we are: first plans go live January 1, 2027, and we'd rather show you the contract than a wall of badges

We'd rather show you the contract than a wall of badges.